Beth C. Seidenberg - Insider Trading & Ownership

Summary
The estimated net worth of Beth C. Seidenberg is at least $17.6M dollars as of June 10, 2025. Beth C. Seidenberg is the Director of Progyny, Inc. and owns shares of Progyny, Inc. (PGNY) stock worth about $9.21M. Beth C. Seidenberg is the Director of Vera Therapeutics, Inc. and owns shares of Vera Therapeutics, Inc. (VERA) stock worth about $6.72M. Beth C. Seidenberg is the Director, 10%+ Owner of Kyverna Therapeutics, Inc. and owns shares of Kyverna Therapeutics, Inc. (KYTX) stock worth about $1.59M. Beth C. Seidenberg is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $45.1K.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Beth C. Seidenberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PGNY Progyny, Inc. Director $9.21M May 23, 2024
VERA Vera Therapeutics, Inc. Director $6.72M May 14, 2025
KYTX Kyverna Therapeutics, Inc. Director, 10%+ Owner $1.59M May 29, 2025
ATRA Atara Biotherapeutics, Inc. Director $45.1K May 31, 2023
SLRN ACELYRIN, Inc. Director $0 May 21, 2025
SGMT Sagimet Biosciences Inc. Director Jun 6, 2025

Insider Transactions Reported by Beth C. Seidenberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.